The acquisition of a 15% stake in Synlab by Labcorp is likely to be seen as a positive strategic move, potentially expanding Labcorp's market presence in Europe. The conditional approval from Italian authorities suggests that the deal is progressing, which could positively impact Labcorp's stock price in the short term.